Keros Therapeutics (KROS) Operating Expenses (2019 - 2026)
Keros Therapeutics (KROS) reported Operating Expenses of $30.94 million for Q2 2026, down 46.6% from $57.99 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Operating Expenses (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Keros Therapeutics' Operating Expenses came in at $148.22 million, down 36.3% year-over-year; for FY2025, it came in at $176.49 million, down 17.7% from FY2024.
- Operating Expenses has a five-year compound annual growth rate of 30.5% (FY2020 to FY2025).
- By year, Operating Expenses came in at $214.38 million in FY2024 (+26.0%), $170.09 million in FY2023 (+48.2%), $114.79 million in FY2022 (+50.1%) and $76.47 million in FY2021 (+63.9%).
- Five-year quarterly Operating Expenses spans a low of $20.2 million in Q3 2021 and a high of $59.21 million in Q1 2025.
- Year over year, Operating Expenses gained in four of the last seven quarters, with an average decline of 7.1%.
- The high point for year-over-year Operating Expenses in five years was Q2 2022 (growth of 96.5%); the low point was Q3 2025 (a decline of 49.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.08 Bn | 1,101.67 Bn | 19.71 Bn | 7.95 Bn |
| 2 | Johnson & Johnson | 616.40 Bn | 534.93 Bn | 17.26 Bn | 10.12 Bn |
| 3 | AbbVie | 501.19 Bn | 474.31 Bn | 12.70 Bn | 10.56 Bn |
| 4 | Merck | 367.18 Bn | 321.56 Bn | 12.21 Bn | 12.80 Bn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 6.09 Bn |
| 6 | Astrazeneca | 261.67 Bn | 235.36 Bn | 12.86 Bn | 9.70 Bn |
| 7 | Amgen | 235.57 Bn | 190.97 Bn | 7.24 Bn | 6.54 Bn |
| 8 | Gilead Sciences | 190.62 Bn | 164.82 Bn | 6.22 Bn | 18.20 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 6.68 Bn |
| 10 | Keros Therapeutics | 221.76 Mn | -1.71 Bn | - | 30.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.94 Mn |
| Dec 31, 2025 | 29.66 Mn |
| Sep 30, 2025 | 29.65 Mn |
| Jun 30, 2025 | 57.99 Mn |
| Mar 31, 2025 | 59.21 Mn |
| Dec 31, 2024 | 56.30 Mn |
| Sep 30, 2024 | 59.05 Mn |
| Jun 30, 2024 | 50.48 Mn |
| Mar 31, 2024 | 48.57 Mn |
| Dec 31, 2023 | 46.60 Mn |
| Sep 30, 2023 | 43.29 Mn |
| Jun 30, 2023 | 41.34 Mn |
| Mar 31, 2023 | 38.87 Mn |
| Dec 31, 2022 | 31.96 Mn |
| Sep 30, 2022 | 27.98 Mn |
| Jun 30, 2022 | 30.73 Mn |
| Mar 31, 2022 | 24.13 Mn |
| Dec 31, 2021 | 24.87 Mn |
| Sep 30, 2021 | 20.20 Mn |
| Jun 30, 2021 | 15.64 Mn |
API Access
Keros Therapeutics Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();